Kisspeptin-10 vs PT-141
One peptide works at the top of the hormonal cascade, the other works directly in the brain's arousal circuitry. This comparison covers HPG axis stimulation vs central melanocortin signalling, and which mechanism fits which research goal.
Kisspeptin-10
Activates KISS1R on GnRH neurons, triggering pulsatile GnRH release — the master upstream signal for LH, FSH, and sex hormone production.
Shop Kisspeptin-10 →PT-141 (Bremelanotide)
Non-selective MC3R/MC4R agonist acting on brain reward and arousal pathways. FDA-approved as Vyleesi for HSDD.
Shop PT-141 (Bremelanotide) →Side-by-Side Comparison
| Factor | Kisspeptin-10 | PT-141 |
|---|---|---|
| Receptor target | KISS1R (on GnRH neurons) | MC3R / MC4R (melanocortin) |
| Mechanism level | Upstream hormonal axis (HPG) | Central nervous system (reward/arousal) |
| Downstream hormone effect | LH, FSH, testosterone, oestrogen elevation | None significant — non-hormonal |
| Regulatory status | Phase 2 research | FDA-approved (Vyleesi, HSDD) |
| Origin | Decapeptide fragment of kisspeptin/metastin | Derived from Melanotan II research |
| Molecular weight | 1,302.5 Da | 1,025.2 Da |
| Best for | Fertility and hypogonadism research | Sexual arousal / desire research |
Mechanism Deep Dive
Kisspeptin-10 — Upstream Hormonal Trigger
Kisspeptin-10 activates KISS1R receptors on GnRH neurons in the hypothalamus, triggering the pulsatile GnRH release that governs the entire reproductive hormonal cascade. Phase 2 trials show significant testosterone elevation in hypogonadal men, positioning it as a research tool for upstream hormonal axis restoration rather than direct arousal.
Shop Kisspeptin-10 →PT-141 — Central Arousal Pathway
PT-141 activates MC3R/MC4R melanocortin receptors in brain reward and arousal circuits, increasing dopamine release in the nucleus accumbens and medial preoptic area. Unlike PDE5 inhibitors or hormonal approaches, its mechanism is entirely central and independent of vascular or endocrine pathways.
Shop PT-141 →Which Peptide Wins For Each Goal?
Testosterone / hypogonadism research
Kisspeptin-10
Directly stimulates the GnRH pulse that drives LH-mediated testosterone production — PT-141 has no meaningful hormonal effect.
Central sexual arousal / desire research
PT-141
FDA-approved (Vyleesi) mechanism acting directly on brain arousal circuitry, independent of hormone levels.
Fertility and ovulation induction research
Kisspeptin-10
Its role as the master upstream GnRH trigger makes it the more directly relevant compound for fertility research.
Isolating hormonal vs central arousal contributions
Both together
Because the two peptides act on non-overlapping systems, researching them in parallel helps separate endocrine-driven from centrally-driven effects on sexual function.
Frequently Asked Questions
What is the difference between Kisspeptin-10 and PT-141?
Kisspeptin-10 acts far upstream, triggering pulsatile GnRH release that raises LH, FSH, and downstream testosterone/oestrogen — a hormonal axis effect. PT-141 acts centrally on melanocortin receptors in brain arousal and reward pathways, directly influencing sexual desire without going through the HPG hormonal cascade.
Which is better for testosterone research: Kisspeptin-10 or PT-141?
Kisspeptin-10 is the more relevant compound for testosterone research — Phase 2 trials show significant testosterone elevation in hypogonadal men through GnRH pulse stimulation. PT-141 does not meaningfully affect testosterone; its research focus is central arousal signalling.
Can Kisspeptin-10 and PT-141 be researched together?
Yes — because they act on non-overlapping systems (upstream hormonal axis vs central arousal circuitry), they are sometimes studied together to separate hormonal-driven effects from centrally-mediated arousal effects on sexual function.
Research use only. All products sold by JA Performance are strictly for laboratory and in vitro research purposes. Not for human consumption, medical use, or veterinary use.